Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Oct;46(8):451-2.
doi: 10.1016/j.aprim.2014.03.008. Epub 2014 May 14.

[Does ezetimibe combined with simvastatin increase the risk of renal failure]

[Article in Spanish]
Eladio Fernández-Liz  1 , Clara Ortí Segarra  2 , Isabel Garrido Mesas  2
Affiliations
Case Reports

[Does ezetimibe combined with simvastatin increase the risk of renal failure]

[Article in Spanish]
Eladio Fernández-Liz et al. Aten Primaria. 2014 Oct.
No abstract available

PubMed Disclaimer

Comment in

  • [Considerations for ezetimibe and renal impairment].
    Pallarés-Carratalá V, Vizcaíno-Castillo B, Górriz-Teruel JL. Pallarés-Carratalá V, et al. Aten Primaria. 2015 Jun-Jul;47(6):388-9. doi: 10.1016/j.aprim.2014.07.011. Epub 2014 Nov 15. Aten Primaria. 2015. PMID: 25454850 Free PMC article. Spanish. No abstract available.
  • [Author's reply].
    Fernández-Liz E, Ortí Segarra C, Garrido Mesas I. Fernández-Liz E, et al. Aten Primaria. 2015 Jun-Jul;47(6):389-91. doi: 10.1016/j.aprim.2014.09.006. Epub 2014 Nov 14. Aten Primaria. 2015. PMID: 25454851 Free PMC article. Spanish. No abstract available.
  • [Development of the "Consensus guidelines for the use of drugs in renal failure"].
    March Pujol MA, Vía Sosa MÀ, Travé Mercadé P, Martínez-Castelao A. March Pujol MA, et al. Aten Primaria. 2017 Nov;49(9):558-560. doi: 10.1016/j.aprim.2016.12.006. Epub 2017 Apr 10. Aten Primaria. 2017. PMID: 28408117 Free PMC article. Spanish. No abstract available.

Similar articles

See all similar articles

Cited by

  • [Considerations for ezetimibe and renal impairment].
    Pallarés-Carratalá V, Vizcaíno-Castillo B, Górriz-Teruel JL. Pallarés-Carratalá V, et al. Aten Primaria. 2015 Jun-Jul;47(6):388-9. doi: 10.1016/j.aprim.2014.07.011. Epub 2014 Nov 15. Aten Primaria. 2015. PMID: 25454850 Free PMC article. Spanish. No abstract available.
  • [Author's reply].
    Fernández-Liz E, Ortí Segarra C, Garrido Mesas I. Fernández-Liz E, et al. Aten Primaria. 2015 Jun-Jul;47(6):389-91. doi: 10.1016/j.aprim.2014.09.006. Epub 2014 Nov 14. Aten Primaria. 2015. PMID: 25454851 Free PMC article. Spanish. No abstract available.
  • [Development of the "Consensus guidelines for the use of drugs in renal failure"].
    March Pujol MA, Vía Sosa MÀ, Travé Mercadé P, Martínez-Castelao A. March Pujol MA, et al. Aten Primaria. 2017 Nov;49(9):558-560. doi: 10.1016/j.aprim.2016.12.006. Epub 2017 Apr 10. Aten Primaria. 2017. PMID: 28408117 Free PMC article. Spanish. No abstract available.

References

    1. Ezetimiba/simvastatina. Dictamen comité de evaluación de nuevos fármacos. Institut Català de la Salut. Departament de Salut. Barcelona 2012 [consultado 10 Feb 2014]. Disponible en: http://10.80.217.110/intranet_ics/suport-activitat/farmacia/avaluacio_no... - DOI
    1. Ezetimiba/simvastatina. Ficha técnica [consultado 10 Feb 2014]. Disponible en: http://www.aemps.gob.es/
    1. The National Collaborating Centre for Chronic Conditions (UK) NICE; 2008. Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care. - PubMed
    1. Madridejos R. Fármacos que deterioran la función renal. FMC. 2012;19:492–498.
    1. Kosoglou T., Statkevich P., Johnson-Levonas A.O., Paolini J.F., Bergman A.J., Alton K.B. Ezetimibe: A review of its metabolism, pharmacokinetics and drug interactions. Clin Pharmacokinet. 2005;44:467–494. - PubMed

MeSH terms